My question is this. What is the actual financial benefit for PAR in repurposing this drug. Doesn't the original patent holder still stand to benefit? How does this work for PAR?
My question is this. What is the actual financial benefit for...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.015(5.88%) |
Mkt cap ! $87.55M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.5¢ | 24.0¢ | $167.2K | 671.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 108741 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 9700 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |